Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
10.54
-0.38 (-3.44%)
At close: Aug 24, 2026, 4:00 PM EDT
10.54
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $17.42 million as of August 24, 2026. Its market cap has increased by 12.37% in one year.
Market Cap
17.42M
Enterprise Value
13.89M
1-Year Change
12.37%
Ranking
Category
Stock Price
$10.54
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $17.42M, a decrease of -4.30%. That is a compound annual growth rate of -0.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 17.42M | 27.13% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 19.56M |
| Polyrizon | 19.28M |
| Palatin Technologies | 18.50M |
| Pluri | 18.45M |
| Pasithea Therapeutics | 18.02M |
| Cyclerion Therapeutics | 17.92M |
| NewcelX | 17.57M |
| Lipocine | 17.23M |